Fig. 2 The mean plasma levels of ADAMTS13 in the 2 groups are shown at different points of time. At 1 week after PCI, the level in the no-reflow group increased markedly over that in the optimal-perfusion group, for a significant difference (P < 0.01).

ADAMTS13 = a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13